Chimeric antigen receptor T cells targeting CD312 as a therapy for acute myeloid leukemia

被引：0
|
作者：
Xie, Danni [1 ]
Wang, Bing [2 ]
Bai, Xue [2 ]
Jin, Xin [3 ]
Lu, Wenyi [2 ]
Zhang, Meng [1 ]
Zhang, Yi [1 ]
Cao, Xinping [1 ]
Zhao, Mingfeng [2 ]
机构：
[1] Tianjin Med Univ, Cent Clin Coll 1, Tianjin 300110, Peoples R China
[2] Tianjin First Cent Hosp, Dept Hematol, Tianjin 300192, Peoples R China
[3] Zhejiang Univ, Med Ctr, Liangzhu Lab, Hangzhou 310011, Zhejiang, Peoples R China
来源：
CHINESE MEDICAL JOURNAL | 2025年 / 138卷 / 01期
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1097/CM9.0000000000003362
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：114 / 116
页数：3
相关论文
共 50 条
  • [31] Recent progress in chimeric antigen receptor therapy for acute myeloid leukemia
    Xiangyu Wang
    Yanming Zhang
    Shengli Xue
    Annals of Hematology, 2024, 103 : 1843 - 1857
  • [32] Recent progress in chimeric antigen receptor therapy for acute myeloid leukemia
    Wang, Xiangyu
    Zhang, Yanming
    Xue, Shengli
    ANNALS OF HEMATOLOGY, 2024, 103 (06) : 1843 - 1857
  • [33] Chimeric antigen receptor T cell therapies for acute myeloid leukemia
    Gu, Bin
    Chu, Jianhong
    Wu, Depei
    FRONTIERS OF MEDICINE, 2020, 14 (06) : 701 - 710
  • [34] Challenges and Advances in Chimeric Antigen Receptor Therapy for Acute Myeloid Leukemia
    Marvin-Peek, Jennifer
    Savani, Bipin N.
    Olalekan, Oluwole O.
    Dholaria, Bhagirathbhai
    CANCERS, 2022, 14 (03)
  • [35] CD33-Directed Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Acute Myeloid Leukemia (AML)
    Rafiq, Sarwish
    Purdon, Terence J.
    Schultz, Liora M.
    Brentjens, Renier J.
    BLOOD, 2016, 128 (22)
  • [36] Chimeric Antigen Receptor-Modified T Cells for the Treatment of Acute Myeloid Leukemia Expressing CD33
    Song, Degang
    Swartz, Michael H.
    Biesecker, Steve G.
    Borda, Fernando
    Shah, Rutul R.
    Emtage, Peter
    Wierda, William G.
    Cooper, Laurence J. N.
    Chan, Tim
    BLOOD, 2016, 128 (22)
  • [37] Therapeutic Targeting of Mesothelin with Chimeric Antigen Receptor Natural Killer Cell Therapy in Acute Myeloid Leukemia
    Tang, Thao T.
    Call, Lindsey F.
    Castro, Sommer
    Nourigat-Mckay, Cynthia
    Perkins, LaKeisha
    Pardo, Laura
    Leonti, Amanda R.
    Meshinchi, Soheil
    Le, Quy
    BLOOD, 2021, 138
  • [38] Current Limitations and Perspectives of Chimeric Antigen Receptor-T-Cells in Acute Myeloid Leukemia
    Maucher, Marius
    Srour, Micha
    Danhof, Sophia
    Einsele, Hermann
    Hudecek, Michael
    Yakoub-Agha, Ibrahim
    CANCERS, 2021, 13 (24)
  • [39] Chimeric antigen receptor (CAR) modified T Cells in acute myeloid leukemia: limitations and expectations
    Guijarro-Albaladejo, Beatriz
    Marrero-Cepeda, Cristina
    Rodriguez-Arboli, Eduardo
    Sierro-Martinez, Belen
    Perez-Simon, Jose Antonio
    Garcia-Guerrero, Estefania
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2024, 12
  • [40] Bispecific CD33/CD123 targeted chimeric antigen receptor T cells for the treatment of acute myeloid leukemia
    Boucher, Justin C.
    Shrestha, Bishwas
    Vishwasrao, Paresh
    Leick, Mark
    Cervantes, Estelle V.
    Ghafoor, Tayyebb
    Reid, Kayla
    Spitler, Kristen
    Yu, Bin
    Betts, Brian C.
    Guevara-Patino, Jose A.
    Maus, Marcela V.
    Davila, Marco L.
    MOLECULAR THERAPY ONCOLYTICS, 2023, 31
12345